C18 orf1, a novel negative regulator of transforming growth factor-β signaling

Journal of Biological Chemistry

Volumn 289, Issue 18, 2014, Pages 12680-12692

  Nakano, Naoko ^a,b   Maeyama, Kota ^a   Sakata, Nobuo ^b   Itoh, Fumiko ^a,c   Akatsu, Ryosuke ^b   Nakata, Miki ^b   Katsu, Yuki ^b   Ikeno, Souichi ^b   Togawa, Yoko ^b   Vo Nguyen, Thanh Thao ^a   Watanabe, Yukihide ^a   Kato, Mitsuyasu ^a   Itoh, Susumu ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; SIGNALING;

CELLS SIGNALING; NEGATIVE REGULATORS; STEADY STATE; TRANSFORMING GROWTH FACTORS;

CELL SIGNALING;

BONE MORPHOGENETIC PROTEIN; MESSENGER RNA; PROTEIN C18ORF1; REGULATOR PROTEIN; SMAD ANCHOR FOR RECEPTOR ACTIVATION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CELL MIGRATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEADY STATE;

ACTIVIN; C18ORF1; EMT; RECEPTOR SERINE/THREONINE KINASE; SARA; SIM; SMAD TRANSCRIPTION FACTOR; TMEPAI; TRANSFORMING GROWTH FACTOR Β (TGFΒ);

AMINO ACID MOTIFS; ANIMALS; BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; HEK293 CELLS; HELA CELLS; HEP G2 CELLS; HUMANS; MEMBRANE PROTEINS; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84899757024     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.558981     Document Type: Article

References (42)

1. Massagué, J., Blain, S. W., and Lo, R. S. (2000) TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103, 295-309
2. Derynck, R., and Akhurst, R. J. (2007) Differentiation plasticity regulated by TGF-β family proteins in development and disease. Nat. Cell Biol. 9, 1000-1004
3. Massagué, J. (2012) TGFβ signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616-630
4. Moustakas, A., and Heldin, C.-H. (2005) Non-Smad TGF-β signals. J. Cell Sci. 118, 3573-3584
5. Hoover, L. L., and Kubalak, S. W. (2008) Holding their own: the noncanonical roles of Smad proteins. Sci. Signal. 1, pe48
6. Zhang, Y. E. (2009) Non-Smad pathways in TGF-β signaling. Cell Res. 19, 128-139
7. Kang, J. S., Liu, C., and Derynck, R. (2009) New regulatory mechanisms of TGF-β receptor function. Trends Cell Biol. 19, 385-394
8. Mu, Y., Gudey, S. K., and Landström, M. (2012) Non-Smad signaling pathways. Cell Tissue Res. 347, 11-20
9. ten Dijke, P., and Arthur, H. M. (2007) Extracellular control of TGFβ signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol. 8, 857-869
10. Gordon, K. J., and Blobe, G. C. (2008) Role of transforming growth factor-β superfamily signaling pathways in human disease. Biochim. Biophys. Acta 1782, 197-228
11. Itoh S., and ten Dijke P. (2007) Negative regulation of TGF-β receptor/ Smad signal transduction. Curr. Opin. Cell Biol. 19, 176-184
12. Itoh, S., and Itoh, F. (2011) Inhibitory machinery for the TGF-β family signaling pathway. Growth Factors 29, 163-173
13. Watanabe, Y., Itoh, S., Goto, T., Ohnishi, E., Inamitsu, M., Itoh, F., Satoh, K., Wiercinska, E., Yang, W., Shi, L., Tanaka, A., Nakano, N., Mommaas, A. M., Shibuya, H., Ten Dijke, P., and Kato, M. (2010) TMEPAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins from active participation in TGF-β signaling. Mol. Cell 37, 123-134
14. Meerabux, J. M., Ohba, H., Iwayama, Y., Maekawa, M., Detera-Wadleigh, S. D., DeLisi, L. E., and Yoshikawa, T. (2009) Analysis of a t(18;21)(p11.1; p11.1) translocation in a family with schizophrenia. J. Hum. Genet. 54, 386-391
15. Kikuchi, M., Yamada, K., Toyota, T., and Yoshikawa, T. (2003) C18orf1 located on chromosome 18p11.2 may confer susceptibility to schizophrenia. J. Med. Dent. Sci. 50, 225-229
16. Kikuchi, M., Yamada, K., Toyota, T., Itokawa, M., Hattori, E., Yoshitsugu, K., Shimizu, H., and Yoshikawa, T. (2003) Two-step association analyses of the chromosome 18p11.2 region in schizophrenia detect a locus encompassing C18orf1. Mol. Psychiatry 8, 467-469
17. Kawabata, M., Inoue, H., Hanyu, A., Imamura, T., and Miyazono, K. (1998) Smad proteins exist as monomers in vivo and undergo homo-and heterooligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17, 4056-4065
18. He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., and Vogelstein, B. (1998) A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95, 2509-2514
19. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S., and Gauthier, J. M. (1998) Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100
20. Jonk, L. J., Itoh, S., Heldin, C.-H., ten Dijke, P., and Kruijer, W. (1998) Identification and functional characterization of an SBE in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273, 21145-21152
21. Itoh, F., Asao, H., Sugamura, K., Heldin, C.-H., ten Dijke, P., and Itoh, S. (2001) Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO J. 20, 4132-4142
22. Itoh, S., Thorikay, M., Kowanetz, M., Moustakas, A., Itoh, F., Heldin, C. H., and ten Dijke, P. (2003) Elucidation of Smad requirement in transforming growth factor-β type I receptor-induced responses. J. Biol. Chem. 278, 3751-3761
23. Noda, D., Itoh, S., Watanabe, Y., Inamitsu, M., Dennler, S., Itoh, F., Koike, S., Danielpour, D., ten Dijke, P., and Kato, M. (2006) ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-β/Smadinduced growth arrest of prostate cells. Oncogene 25, 5591-5600
24. Nakano, N., Itoh, S., Watanabe, Y., Maeyama, K., Itoh, F., and Kato, M. (2010) Requirement of TCF7L2 for TGF-β-dependent transcriptional activation of the TMEPAI gene. J. Biol. Chem. 285, 38023-38033
25. Persson, U., Izumi, H., Souchelnytskyi, S., Itoh, S., Grimsby, S., Engström, U., Heldin, C. H., Funa, K., and ten Dijke, P. (1998) The L45 loop in type I receptors for TGF-β family members is a critical determinant in specifying Smad isoform activation. FEBS Lett. 434, 83-87
26. Itoh, F., Divecha, N., Brocks, L., Oomen, L., Janssen, H., Calafat, J., Itoh, S., and Dijke Pt Pt (2002) The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-β/Smad signalling. Genes Cells 7, 321-331
27. Tsukazaki, T., Chiang, T. A., Davison, A. F., Attisano, L., and Wrana, J. L. (1998)AFYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell 95, 779-791
28. Reynisdóttir, I., Polyak, K., Iavarone, A., and Massagué, J. (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9, 1831-1845
29. Verrecchia, F., Tacheau, C., Schorpp-Kistner, M., Angel, P., and Mauviel, A. (2001) Induction of the AP-1 members c-Jun and JunB by TGF-β/Smad suppresses early Smad-driven gene activation. Oncogene 20, 2205-2211
30. Bakkebø, M., Huse, K., Hilden, V. I., Forfang, L., Myklebust, J. H., Smeland, E. B., and Oksvold, M. P. (2012) SARA is dispensable for functional TGF-β signaling. FEBS Lett. 586, 3367-3372
31. Chen, Y. G., Wang, Z., Ma, J., Zhang, L., and Lu, Z. (2007) Endofin, a FYVE domain protein, interacts with Smad4 and facilitates transforming growth factor-β signaling. J. Biol. Chem. 282, 9688-9695
32. Miura, S., Takeshita, T., Asao, H., Kimura, Y., Murata, K., Sasaki, Y., Hanai, J. I., Beppu, H., Tsukazaki, T., Wrana, J. L., Miyazono, K., and Sugamura, K. (2000) Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol. Cell. Biol. 20, 9346-9355
33. Bierie, B., and Moses, H. L. (2006) Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 6, 506-520
34. Massagué, J. (2008) TGFβ in cancer. Cell 134, 215-230
35. Inman, G. J. (2011) Switching TGFβ from a tumor suppressor to a tumor promoter. Curr. Opin. Genet. Dev. 21, 93-99
36. Meulmeester, E., and Ten Dijke, P. (2011) The dynamic roles of TGF-β in cancer. J. Pathol. 223, 205-218
37. Hirokawa, Y. S., Takagi, A., Uchida, K., Kozuka, Y., Yoneda, M., Watanabe, M., and Shiraishi, T. (2007) High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone. Cell. Mol. Biol. Lett. 12, 370-377
38. Hofsli, E., Wheeler, T. E., Langaas, M., Laegreid, A., and Thommesen, L. (2008) Identification of novel neuroendocrine-specific tumour genes. Br. J. Cancer 99, 1330-1339
39. Reichling, T., Goss, K. H., Carson, D. J., Holdcraft, R. W., Ley-Ebert, C., Witte, D., Aronow, B. J., and Groden, J. (2005) Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. Cancer Res. 65, 166-176
40. Giannini, G., Ambrosini, M. I., Di Marcotullio, L., Cerignoli, F., Zani, M., MacKay, A. R., Screpanti, I., Frati, L., and Gulino, A. (2003) EGF-and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer. Mol. Carcinog. 38, 188-200
41. Brunschwig, E. B., Wilson, K., Mack, D., Dawson, D., Lawrence, E., Willson, J. K., Lu, S., Nosrati, A., Rerko, R. M., Swinler, S., Beard, L., Lutterbaugh, J. D., Willis, J., Platzer, P., and Markowitz, S. (2003) PMEPA1, a transforming growth factor-β-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. Cancer Res. 63, 1568-1575
42. Sun, M., Gewirtz, J. C., Bofenkamp, L., Wickham, R. J., Ge, H., and O'Connor, M. B. (2010) Canonical TGF-β signaling is required for the balance of excitatory/inhibitory transmission within the hippocampus and prepulse inhibition of acoustic startle. J. Neurosci. 30, 6025-6035